Facebook tracking pixel
I25.5
ICD-10-CM
Ischemic Congestive Cardiomyopathy

Find information on Ischemic Congestive Cardiomyopathy including diagnosis codes, clinical documentation improvement tips, and healthcare resources. Learn about ICD-10-CM codes for Ischemic Cardiomyopathy, congestive heart failure, and related cardiovascular conditions. Explore guidance on accurate medical coding and documentation for optimal reimbursement and improved patient care. This resource offers insights for physicians, coders, and other healthcare professionals seeking information on Ischemic Congestive Cardiomyopathy management, treatment, and coding best practices.

Also known as

Ischemic Cardiomyopathy
Coronary Artery Disease Cardiomyopathy

Diagnosis Snapshot

Key Facts
  • Definition : Heart muscle weakened due to reduced blood flow, leading to fluid buildup.
  • Clinical Signs : Shortness of breath, fatigue, swelling in legs and ankles, chest pain.
  • Common Settings : Hospital cardiology units, outpatient heart failure clinics.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC I25.5 Coding
I11.0

Hypertensive heart disease with heart failure

Heart failure due to high blood pressure.

I25.5

Ischemic cardiomyopathy

Weakened heart muscle due to reduced blood flow.

I50.x

Heart failure

Heart's inability to pump blood effectively.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the cardiomyopathy ischemic?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Ischemic congestive cardiomyopathy
Dilated cardiomyopathy
Hypertrophic cardiomyopathy

Documentation Best Practices

Documentation Checklist
  • Ischemic congestive cardiomyopathy diagnosis documentation:
  • Document LVEF measurements/estimations.
  • Evidence of coronary artery disease (CAD).
  • Symptoms of heart failure (HF) detailed.
  • Exclude non-ischemic causes of cardiomyopathy.
  • ICD-10-CM code I25.5 confirmed and supported.

Coding and Audit Risks

Common Risks
  • Unspecified Etiology

    Coding I25.5 requires documentation of the ischemic cause. Unspecified etiology leads to coding errors and claim denials.

  • CHF vs. Cardiomyopathy

    Differentiating between congestive heart failure (CHF) and cardiomyopathy is crucial for accurate coding. Overlapping symptoms can cause miscoding.

  • Atherosclerosis Documentation

    Underlying atherosclerosis must be clearly documented and linked to the cardiomyopathy for accurate I25.5 coding and proper reimbursement.

Mitigation Tips

Best Practices
  • Document LV dysfunction, MI history, and angina for accurate ICD-10-CM I51.7 coding.
  • Thorough exam findings and echo results are key for Ischemic Cardiomyopathy diagnosis.
  • Specificity in clinical documentation improves CDI and risk adjustment accuracy.
  • Query physicians for clarification on etiology and comorbidities to ensure complete coding.
  • Regularly review coding guidelines and updates for Ischemic Cardiomyopathy (I51.7) compliance.

Clinical Decision Support

Checklist
  • 1. HFrEF symptoms present? (e.g., dyspnea, fatigue)
  • 2. CAD confirmed? (angiography, stress test)
  • 3. LV systolic dysfunction? (EF <40%, imaging)
  • 4. No valvular or other causes of cardiomyopathy?

Reimbursement and Quality Metrics

Impact Summary
  • Ischemic Congestive Cardiomyopathy: Reimbursement and Quality Metrics Impact Summary
  • Keywords: ICD-10-CM I51.71, CHF, heart failure, medical coding, billing compliance, DRG assignment, quality reporting, MACRA, MIPS, hospital reimbursement
  • Impact 1: Accurate I51.71 coding maximizes appropriate reimbursement.
  • Impact 2: Impacts heart failure core measure reporting and hospital value-based purchasing.
  • Impact 3: Proper documentation supports risk adjustment and severity scoring for optimal payment.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code I25.5 and I50.x
  • Document ischemia and CHF
  • Specify etiology of ischemia
  • Query physician if unclear
  • Review echo for LV dysfunction

Documentation Templates

Patient presents with symptoms suggestive of ischemic congestive cardiomyopathy (ICM).  Key complaints include dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, and fatigue.  Physical examination reveals pulmonary rales, jugular venous distention, and peripheral edema.  The patient reports a history of coronary artery disease (CAD) with prior myocardial infarction.  Electrocardiogram (ECG) demonstrates evidence of prior MI and left ventricular hypertrophy (LVH).  Echocardiography shows reduced left ventricular ejection fraction (LVEF) consistent with systolic heart failure, regional wall motion abnormalities indicative of ischemia, and left ventricular dilation.  Cardiac biomarkers, including troponin and BNP (brain natriuretic peptide), are elevated.  The diagnosis of ischemic congestive cardiomyopathy is made based on the patient's clinical presentation, history of CAD, and diagnostic testing results.  The patient's current condition is assessed as New York Heart Association (NYHA) functional class III heart failure.  Treatment plan includes optimal medical therapy for heart failure with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), beta-blockers, and diuretics.  Referral to cardiology for consideration of coronary angiography and potential revascularization procedures, such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), will be made.  Patient education provided regarding medication adherence, lifestyle modifications including sodium restriction and fluid management, and the importance of follow-up appointments.  ICD-10 code I51.71 (ischemic cardiomyopathy with heart failure) and appropriate CPT codes for evaluation and management (E/M) services will be documented for billing and coding purposes.  Prognosis discussed with the patient, emphasizing the importance of ongoing management and adherence to treatment recommendations to improve cardiac function and quality of life.